Skip to main content
NCBI home page
The British Journal of Ophthalmology logoLink to The British Journal of Ophthalmology
. 1986 Apr;70(4):281–283. doi: 10.1136/bjo.70.4.281

Delayed-onset chloroquine retinopathy.

M Ehrenfeld, R Nesher, S Merin
PMCID: PMC1040997  PMID: 3964626

Abstract

Delayed-onset chloroquine retinopathy was diagnosed in a patient seven years after cessation of treatment by a total dose of 730 g of chloroquine for rheumatoid arthritis. Visual functions continued to deteriorate after the diagnosis. Periodic examinations by ophthalmoscopy and by functional tests such as EOG and visual fields should be continued in patients at risk of delayed-onset chloroquine retinopathy after discontinuance of the drug.

Full text

PDF
281

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BERNSTEIN H., ZVAIFLER N., RUBIN M., MANSOUR A. M. THE OCULAR DEPOSITION OF CHLOROQUINE. Invest Ophthalmol. 1963 Aug;2:384–392. [PubMed] [Google Scholar]
  2. Bernstein H. N. Chloroquine ocular toxicity. Surv Ophthalmol. 1967 Oct;12(5):415–447. [PubMed] [Google Scholar]
  3. Bernstein H. N. Ophthalmologic considerations and testing in patients receiving long-term antimalarial therapy. Am J Med. 1983 Jul 18;75(1A):25–34. doi: 10.1016/0002-9343(83)91267-6. [DOI] [PubMed] [Google Scholar]
  4. Brinkley J. R., Jr, Dubois E. L., Ryan S. J. Long-term course of chloroquine retinopathy after cessation of medication. Am J Ophthalmol. 1979 Jul;88(1):1–11. doi: 10.1016/0002-9394(79)90743-8. [DOI] [PubMed] [Google Scholar]
  5. Burns R. P. Delayed onset of chloroquine retinopathy. N Engl J Med. 1966 Sep 29;275(13):693–696. doi: 10.1056/NEJM196609292751303. [DOI] [PubMed] [Google Scholar]
  6. Carr R. E., Henkind P., Rothfield N., Siegel I. M. Ocular toxicity of antimalarial drugs. Long-term follow-up. Am J Ophthalmol. 1968 Oct;66(4):738–744. doi: 10.1016/0002-9394(68)91300-7. [DOI] [PubMed] [Google Scholar]
  7. HOBBS H. E., CALNAN C. D. The ocular complications of chloroquine therapy. Lancet. 1958 Jun 7;1(7032):1207–1209. doi: 10.1016/s0140-6736(58)91911-1. [DOI] [PubMed] [Google Scholar]
  8. HOBBS H. E., SORSBY A., FREEDMAN A. Retinopathy following chloroquine therapy. Lancet. 1959 Oct 3;2(7101):478–480. doi: 10.1016/s0140-6736(59)90604-x. [DOI] [PubMed] [Google Scholar]
  9. Mackenzie A. H. Antimalarial drugs for rheumatoid arthritis. Am J Med. 1983 Dec 30;75(6A):48–58. doi: 10.1016/0002-9343(83)90474-6. [DOI] [PubMed] [Google Scholar]
  10. Nylander U. Ocular damage in chloroquine therapy. Acta Ophthalmol (Copenh) 1966;44(3):335–348. [PubMed] [Google Scholar]
  11. OKUN E., GOURAS P., BERNSTEIN H., VON SALLMANN L. Chloroquine retinopathy; a report of eight cases with ERG and dark-adaptation findings. Arch Ophthalmol. 1963 Jan;69:59–71. doi: 10.1001/archopht.1963.00960040065013. [DOI] [PubMed] [Google Scholar]
  12. Ogawa S., Kurumatani N., Shibaike N., Yamazoe S. Progression of retinopathy long after cessation of chloroquine therapy. Lancet. 1979 Jun 30;1(8131):1408–1408. doi: 10.1016/s0140-6736(79)92044-0. [DOI] [PubMed] [Google Scholar]
  13. Reed H., Karlinsky W. Delayed onset of chloroquine retinopathy. Can Med Assoc J. 1967 Dec 2;97(23):1408–1411. [PMC free article] [PubMed] [Google Scholar]
  14. Voipio H. Incidence of chloroquine retinopathy. Acta Ophthalmol (Copenh) 1966;44(3):349–354. doi: 10.1111/j.1755-3768.1966.tb08040.x. [DOI] [PubMed] [Google Scholar]

Articles from The British Journal of Ophthalmology are provided here courtesy of BMJ Publishing Group

RESOURCES